CN205549077U - 一种用于制备微凝胶的微流控装置 - Google Patents
一种用于制备微凝胶的微流控装置 Download PDFInfo
- Publication number
- CN205549077U CN205549077U CN201620207509.8U CN201620207509U CN205549077U CN 205549077 U CN205549077 U CN 205549077U CN 201620207509 U CN201620207509 U CN 201620207509U CN 205549077 U CN205549077 U CN 205549077U
- Authority
- CN
- China
- Prior art keywords
- microchannel
- port
- microgel
- cell
- micro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000000975 bioactive effect Effects 0.000 claims abstract description 13
- 238000003780 insertion Methods 0.000 claims description 16
- 230000037431 insertion Effects 0.000 claims description 16
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 230000002209 hydrophobic effect Effects 0.000 claims description 4
- 238000000034 method Methods 0.000 abstract description 68
- 238000002360 preparation method Methods 0.000 abstract description 25
- 230000004083 survival effect Effects 0.000 abstract description 13
- 238000009826 distribution Methods 0.000 abstract description 9
- 210000004027 cell Anatomy 0.000 description 91
- 239000012071 phase Substances 0.000 description 87
- 239000003921 oil Substances 0.000 description 72
- 235000019198 oils Nutrition 0.000 description 71
- 239000000839 emulsion Substances 0.000 description 64
- 239000000243 solution Substances 0.000 description 38
- 239000007864 aqueous solution Substances 0.000 description 33
- 239000012530 fluid Substances 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 239000004094 surface-active agent Substances 0.000 description 21
- 210000001082 somatic cell Anatomy 0.000 description 19
- 239000000017 hydrogel Substances 0.000 description 18
- 229920000642 polymer Polymers 0.000 description 18
- 239000000499 gel Substances 0.000 description 15
- 239000008346 aqueous phase Substances 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 11
- 239000004531 microgranule Substances 0.000 description 10
- 239000004372 Polyvinyl alcohol Substances 0.000 description 9
- 238000004132 cross linking Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 238000001000 micrograph Methods 0.000 description 9
- 229920002451 polyvinyl alcohol Polymers 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000000178 monomer Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 230000012010 growth Effects 0.000 description 7
- 238000006116 polymerization reaction Methods 0.000 description 7
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- 239000000600 sorbitol Substances 0.000 description 6
- -1 sorbitol anhydride lauric acid Ester Chemical class 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000006143 cell culture medium Substances 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 5
- 229910021641 deionized water Inorganic materials 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 210000002950 fibroblast Anatomy 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 108010010803 Gelatin Proteins 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000004945 emulsification Methods 0.000 description 4
- 239000007863 gel particle Substances 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 210000001822 immobilized cell Anatomy 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 238000005461 lubrication Methods 0.000 description 4
- 235000010446 mineral oil Nutrition 0.000 description 4
- 239000002480 mineral oil Substances 0.000 description 4
- 238000010008 shearing Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000002659 cell therapy Methods 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 125000004386 diacrylate group Chemical group 0.000 description 3
- 210000003725 endotheliocyte Anatomy 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 229920000554 ionomer Polymers 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000007711 solidification Methods 0.000 description 3
- 230000008023 solidification Effects 0.000 description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- 229920001730 Moisture cure polyurethane Polymers 0.000 description 2
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 2
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 2
- 238000010923 batch production Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 238000010924 continuous production Methods 0.000 description 2
- 210000004292 cytoskeleton Anatomy 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000005468 ion implantation Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920000671 polyethylene glycol diacrylate Polymers 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- QNODIIQQMGDSEF-UHFFFAOYSA-N (1-hydroxycyclohexyl)-phenylmethanone Chemical compound C=1C=CC=CC=1C(=O)C1(O)CCCCC1 QNODIIQQMGDSEF-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- KWVGIHKZDCUPEU-UHFFFAOYSA-N 2,2-dimethoxy-2-phenylacetophenone Chemical compound C=1C=CC=CC=1C(OC)(OC)C(=O)C1=CC=CC=C1 KWVGIHKZDCUPEU-UHFFFAOYSA-N 0.000 description 1
- GJKGAPPUXSSCFI-UHFFFAOYSA-N 2-Hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone Chemical compound CC(C)(O)C(=O)C1=CC=C(OCCO)C=C1 GJKGAPPUXSSCFI-UHFFFAOYSA-N 0.000 description 1
- MGYUQZIGNZFZJS-KTKRTIGZSA-N 2-[2-[(z)-octadec-9-enoxy]ethoxy]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCOCCO MGYUQZIGNZFZJS-KTKRTIGZSA-N 0.000 description 1
- BRTHMFXKGHIZAM-UHFFFAOYSA-N 2-hydroxy-1-phenylheptan-1-one Chemical compound CCCCCC(O)C(=O)C1=CC=CC=C1 BRTHMFXKGHIZAM-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- QYOVMAREBTZLBT-KTKRTIGZSA-N CCCCCCCC\C=C/CCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO QYOVMAREBTZLBT-KTKRTIGZSA-N 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- LWZFANDGMFTDAV-WYDSMHRWSA-N [2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical group CCCCCCCCCCCC(=O)OCC(O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-WYDSMHRWSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- 239000012867 bioactive agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000006364 cellular survival Effects 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Polymers OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- UAZRLZKBADJCKK-UHFFFAOYSA-N imidazolidine-2,4-dione;sodium Chemical compound [Na].O=C1CNC(=O)N1 UAZRLZKBADJCKK-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000012606 in vitro cell culture Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 150000005217 methyl ethers Chemical class 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-N methyl undecanoic acid Natural products CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 208000025113 myeloid leukemia Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000004537 potential cytotoxicity Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- YUYCVXFAYWRXLS-UHFFFAOYSA-N trimethoxysilane Chemical compound CO[SiH](OC)OC YUYCVXFAYWRXLS-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201620207509.8U CN205549077U (zh) | 2016-03-16 | 2016-03-16 | 一种用于制备微凝胶的微流控装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201620207509.8U CN205549077U (zh) | 2016-03-16 | 2016-03-16 | 一种用于制备微凝胶的微流控装置 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN205549077U true CN205549077U (zh) | 2016-09-07 |
Family
ID=56814995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201620207509.8U Active CN205549077U (zh) | 2016-03-16 | 2016-03-16 | 一种用于制备微凝胶的微流控装置 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN205549077U (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105641743A (zh) * | 2016-03-16 | 2016-06-08 | 王华楠 | 一种微流控装置及利用该装置制备微凝胶的方法 |
CN107930542A (zh) * | 2017-11-13 | 2018-04-20 | 王华楠 | 一步法连续制备海藻酸钙微凝胶的微流控技术 |
CN109652359A (zh) * | 2017-10-12 | 2019-04-19 | 中国科学院大连化学物理研究所 | 一种基于双水相液滴的细胞3d培养水凝胶微球的制备方法 |
CN110201612A (zh) * | 2019-05-20 | 2019-09-06 | 浙江大学 | 一种基于荧光微球监测肌细胞力学性质和收缩频率的核壳结构微球及其应用 |
CN115646567A (zh) * | 2022-12-26 | 2023-01-31 | 南京师范大学 | 集成液滴在线培养和高通量筛选功能的微流控芯片及其应用 |
-
2016
- 2016-03-16 CN CN201620207509.8U patent/CN205549077U/zh active Active
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105641743A (zh) * | 2016-03-16 | 2016-06-08 | 王华楠 | 一种微流控装置及利用该装置制备微凝胶的方法 |
CN105641743B (zh) * | 2016-03-16 | 2019-05-17 | 宁波瑞柏思生物材料科技有限公司 | 一种微流控装置及利用该装置制备微凝胶的方法 |
CN109652359A (zh) * | 2017-10-12 | 2019-04-19 | 中国科学院大连化学物理研究所 | 一种基于双水相液滴的细胞3d培养水凝胶微球的制备方法 |
CN107930542A (zh) * | 2017-11-13 | 2018-04-20 | 王华楠 | 一步法连续制备海藻酸钙微凝胶的微流控技术 |
CN107930542B (zh) * | 2017-11-13 | 2020-11-20 | 深圳华诺生物科技有限公司 | 一步法连续制备海藻酸钙微凝胶的微流控技术 |
CN110201612A (zh) * | 2019-05-20 | 2019-09-06 | 浙江大学 | 一种基于荧光微球监测肌细胞力学性质和收缩频率的核壳结构微球及其应用 |
CN115646567A (zh) * | 2022-12-26 | 2023-01-31 | 南京师范大学 | 集成液滴在线培养和高通量筛选功能的微流控芯片及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105641743B (zh) | 一种微流控装置及利用该装置制备微凝胶的方法 | |
CN205549077U (zh) | 一种用于制备微凝胶的微流控装置 | |
CN110997900B (zh) | 用于快速产生用于化合物筛选的类器官/球状体的微流体平台 | |
US6399341B1 (en) | Artificial pancreas | |
Xie et al. | Composable microfluidic spinning platforms for facile production of biomimetic perfusable hydrogel microtubes | |
CN108721684A (zh) | 一种核壳型预装化疗药物栓塞微球及其制备方法 | |
Mazzitelli et al. | Optimised production of multifunctional microfibres by microfluidic chip technology for tissue engineering applications | |
JP5945802B2 (ja) | 複合型肝細胞組織体およびその作製方法 | |
CN106309407A (zh) | 一种具有核壳结构的复合药物微载体 | |
CN107298767A (zh) | 一种基于微流控芯片装置的明胶纳米微粒的连续制备方法 | |
CN112409553B (zh) | 微流控冰晶法制备可注射多孔水凝胶微球的方法及其应用 | |
CN103132163A (zh) | 一种具有多重核壳结构的纤维及其制备方法 | |
KR102102153B1 (ko) | 탈세포 조직 기반 세포 봉입 및 배양용 비드, 및 이의 용도 | |
CN113975250A (zh) | 一种具有核壳结构的双水相多孔胰岛微胶囊的制备及应用 | |
CN109806919A (zh) | 一种3d细胞培养的明胶甲基丙烯酰胺核壳微球的制备方法 | |
CN103131665A (zh) | 一种复合结构编码微载体及其制备方法和应用 | |
Rosellini et al. | Microfluidic Fabrication of Natural Polymer-Based Scaffolds for Tissue Engineering Applications: A Review | |
Mohajeri et al. | Cell encapsulation in alginate-based microgels using droplet microfluidics; a review on gelation methods and applications | |
CN113769161A (zh) | 一种用于骨组织再生的近红外光响应性仿生血管支架及其制备方法 | |
Zhang et al. | One-step generation and purification of cell-encapsulated hydrogel microsphere with an easily assembled microfluidic device | |
PT105489B (pt) | Dispositivo, método e sistema de fabrico de microcápsulas | |
CN103146636A (zh) | 一种分级结构微载体及其制备方法和应用 | |
EP4146394A1 (de) | Mikrofluidische vorrichtung | |
CN109810935B (zh) | 细胞分区培养的明胶甲基丙烯酰胺核壳微球的制备方法 | |
CN113755425B (zh) | 一种载三维胰岛β细胞聚集体的多孔微载体的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181023 Address after: 315042 room 494, 2 building, 66 business building, academician Road, Ningbo high tech Zone, Zhejiang, China Patentee after: Ningbo bio bio Mstar Technology Ltd Address before: 116000 College of life sciences, Dalian University of Technology, 2 linggong Road, hi tech park, Dalian, Liaoning Patentee before: Wang Huanan |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220408 Address after: 518104 Houting Community, Shajing Street, Baoan District, Shenzhen City, Guangdong Province Patentee after: SHENZHEN HUA-NOVA BIOTECHNOLOGY Ltd. Address before: 315042 room 494, 2 building, 66 business building, academician Road, Ningbo high tech Zone, Zhejiang, China Patentee before: Ningbo bio bio Mstar Technology Ltd. |
|
TR01 | Transfer of patent right |